ISRAEL CANCER RESEARCH FUND INC
ISRAEL CANCER RESEARCH FUND INC
ISRAEL CANCER RESEARCH FUND INC
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$9,064,574
Contributions
64%
Fundraising Events
21%
Other
10%
Investments
6%
Government Grants
0%
Program Services
0%
Membership Dues
0%
Expenses in 2024
$6,298,074
Grants
58%
Salaries & Benefits
30%
Fees to Service Providers
5%
Offices, Occupancy & IT
3%
Other
2%
Depreciation
<1%
Advertising & Promotion
<1%
Interest
<1%
Benefits to Members
0%
Revenues
2023
2024
Change
Contributions
$5,918,876
$5,780,664
-2%
Government Grants
$0
$0
-
Fundraising Events
$1,865,031
$1,888,965
+1%
Program Services
$0
$0
-
Membership Dues
$0
$0
-
Investments
$198,980
$502,721
+153%
Other
-$254,716
$892,224
-450%
Total Revenues
$7,728,171
$9,064,574
+17%
Expenses
2023
2024
Change
Grants
$3,461,666
$3,657,154
+6%
Benefits to Members
$0
$0
-
Salaries & Benefits
$2,088,197
$1,864,230
-11%
Fees to Service Providers
$344,983
$334,677
-3%
Advertising & Promotion
$35,622
$44,608
+25%
Offices, Occupancy & IT
$270,231
$196,249
-27%
Interest
$0
$5,353
-
Depreciation
$64,522
$62,170
-4%
Other
$88,074
$133,633
+52%
Total Expenses
$6,353,295
$6,298,074
-1%
Net income
2023
2024
Change
Net income
+$1,374,876
+$2,766,500
+101%
Functional Expenses
Summary
2023
2024
Change
Program
$4,276,319
$4,397,049
+3%
Admin
$702,792
$676,706
-4%
Fundraising
$1,374,184
$1,224,319
-11%
Total Expenses
$6,353,295
$6,298,074
-1%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)